Activation of Raf-1 in Human Pancreatic Adenocarcinoma

作者: David H. Berger , Lori A. Jardines , Hong Chang , Bruce Ruggeri

DOI: 10.1006/JSRE.1997.5022

关键词: AdenocarcinomaPancreasOncogeneMAPK/ERK pathwayPancreatic diseaseBiologyEndocrinologyMutationPoint mutationMolecular biologyPancreatic cancerInternal medicine

摘要: Abstract Point mutations in the Ras oncogene cause to remain its active GTP-bound state sending signals downstream continuously. Since 75 90% of all human pancreatic ductal adenocarcinomas harbor activating at codon 12 K-ras it was our belief that Raf-1–;MEK–;MAPK will be activated majority cancers. The aim this study confirm activation Raf-1 mutant cancer. Additionally, we sought determine if differed and nonmutant Futhermore, were interested determining cancer led subsequent effectors such as MAP kinase. presence 14 adenocarcinoma cell lines determined by use allele-specific PCR restriction fragment length polymorphism analysis. expression quiescent cells immunoblotting using a rabbit anti-human polyclonal antibody enhanced chemiluminescence. kinase activity measuring incorporation phosphate into Myelin Basic Protein. Seven noted have while seven did not. There no difference 74 kDa-activated form vs lines. However, there significant increase compared with (P= 0.026). We conclude is expressed regardless status. signaling differs those without mutations.

参考文章(30)
N S Magnuson, U Smola, H Vahidi, H Hahn, T Beck, U R Rapp, The Raf-1 serine/threonine protein kinase Seminars in Cancer Biology. ,vol. 5, pp. 247- 253 ,(1994)
S. Li, P. Janosch, M. Tanji, G.C. Rosenfeld, J.C. Waymire, H. Mischak, W. Kolch, J.M. Sedivy, Regulation of Raf-1 kinase activity by the 14-3-3 family of proteins. The EMBO Journal. ,vol. 14, pp. 685- 696 ,(1995) , 10.1002/J.1460-2075.1995.TB07047.X
R. H. Hruban, T. W. Kensler, D. H.J. Van Weering, J. L. Cameron, S. N. Goodman, A. D.M. Van Mansfeld, K. K. Bose, David C. Allison, G. J.A. Offerhaus, J. L. Bos, K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. American Journal of Pathology. ,vol. 143, pp. 545- 554 ,(1993)
Sally Cowley, Hugh Paterson, Pauline Kemp, Christopher J Marshall, Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells Cell. ,vol. 77, pp. 841- 852 ,(1994) , 10.1016/0092-8674(94)90133-3
N. G. Williams, H. Paradis, S. Agarwal, D. L. Charest, S. L. Pelech, T. M. Roberts, Raf-1 and p21v-ras cooperate in the activation of mitogen-activated protein kinase Proceedings of the National Academy of Sciences of the United States of America. ,vol. 90, pp. 5772- 5776 ,(1993) , 10.1073/PNAS.90.12.5772
Sally J. Leevers, Hugh F. Paterson, Christopher J. Marshall, Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane Nature. ,vol. 369, pp. 411- 414 ,(1994) , 10.1038/369411A0
Ursula S. Vogel, Richard A. F. Dixon, Michael D. Schaber, Ronald E. Diehl, Mark S. Marshall, Edward M. Scolnick, Irving S. Sigal, Jackson B. Gibbs, Cloning of bovine GAP and its interaction with oncogenic ras p21 Nature. ,vol. 335, pp. 90- 93 ,(1988) , 10.1038/335090A0
Patricia H. Warne, Pablo Rodrigueza Vician, Julian Downward, Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro Nature. ,vol. 364, pp. 352- 355 ,(1993) , 10.1038/364352A0